Novel 2-substituted cocaine analogs: uptake and ligand binding studies at dopamine, serotonin and norepinephrine transport sites in the rat brain

BA Bennett, CH Wichems, CK Hollingsworth, HM Davies, C Thornley, T Sexton and SR Childers

Department of Physiology and Pharmacology, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, North Carolina.

A novel scheme utilizing vinylcarbenoid precursors has been developed for the synthesis of tropane analogs of cocaine. Specificities of these compounds for dopamine (DA), serotonin (5-HT) or norepinephrine (NE) transporters were determined by both uptake inhibition and binding assays. In each of the analogs, the aryl group at position 3 was bound directly to the tropane ring (as in WIN-35,428), and methyl or ethyl ketone moieties were present at position 2 in lieu of the ester linkage present in cocaine. The addition of methyl or ethyl ketone groups in position 2 did not affect potency compared to ester groups in the same position, but substituents on the benzene ring greatly affected potencies. The analogs could be categorized according to their relative specificity, which consisted of those selective for DA and NE transporters with little affinity for the 5-HT transporter (e.g., WF- 39), those selective for only the DA transporter (e.g., WF-29) and those selective for the 5-HT transporter (e.g., WF-31) with much less affinity for the DA and NE transporters. There also were those analogs (e.g., WF-23) with high affinity, but with equal affinity at all three transporters. The analogs displayed significant correlation between uptake inhibition and binding displacement at DA, 5-HT and NE transport sites. These results suggest that large variations in the tropane structure do not result in a differentiation between binding at biogenic amine transporters and inhibition of amine uptake.

Volume 272, Issue 3, pp. 1176-1186, 03/01/1995
Copyright © 1995 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				V. Murthy, T. J. Martin, S. Kim, H. M. L. Davies, and S. R. Childers In Vivo Characterization of a Novel Phenylisothiocyanate Tropane Analog at Monoamine Transporters in Rat Brain J. Pharmacol. Exp. Ther., August 1, 2008; 326(2): 587 - 595. [Abstract] [Full Text] [PDF]

				K. A. O'Connor, L. J. Porrino, H. M. L. Davies, and S. R. Childers Time-Dependent Changes in Receptor/G-Protein Coupling in Rat Brain following Chronic Monoamine Transporter Blockade J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 510 - 517. [Abstract] [Full Text] [PDF]

				J. A. Lile, Z. Wang, W. L. Woolverton, J. E. France, T. C. Gregg, H. M. L. Davies, and M. A. Nader The Reinforcing Efficacy of Psychostimulants in Rhesus Monkeys: The Role of Pharmacokinetics and Pharmacodynamics J. Pharmacol. Exp. Ther., October 1, 2003; 307(1): 356 - 366. [Abstract] [Full Text] [PDF]

				J. A. Lile, D. Morgan, A. M. Birmingham, Z. Wang, W. L. Woolverton, H. M. L. Davies, and M. A. Nader The Reinforcing Efficacy of the Dopamine Reuptake Inhibitor 2beta -Propanoyl-3beta -(4-tolyl)-tropane (PTT) as Measured by a Progressive-Ratio Schedule and a Choice Procedure in Rhesus Monkeys J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 640 - 648. [Abstract] [Full Text] [PDF]

				S. R. Letchworth, H. R. Smith, L. J. Porrino, B. A. Bennett, H. M. L. Davies, T. Sexton, and S. R. Childers Characterization of a Tropane Radioligand, [3H]2beta -Propanoyl-3beta -(4-tolyl) Tropane ([3H]PTT), for Dopamine Transport Sites in Rat Brain J. Pharmacol. Exp. Ther., May 1, 2000; 293(2): 686 - 696. [Abstract] [Full Text]

				J. B. Daunais, S. L. Hart, H. R. Smith, S. R. Letchworth, H. M. L. Davies, T. Sexton, B.A. Bennett, S. R. Childers, and L. J. Porrino Long-Acting Blockade of Biogenic Amine Transporters in Rat Brain by Administration of the Potent Novel Tropane 2beta -Propanoyl-3beta -(2-Naphthyl)-Tropane J. Pharmacol. Exp. Ther., June 1, 1998; 285(3): 1246 - 1254. [Abstract] [Full Text] [PDF]

				S. E. Hemby, I. Lucki, G. Gatto, A. Singh, C. Thornley, J. Matasi, N. Kong, J. E. Smith, H. M. L. Davies, and S. I. Dworkin Potential Antidepressant Effects of Novel Tropane Compounds, Selective for Serotonin or Dopamine Transporters J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 727 - 733. [Abstract] [Full Text]

				M. A. Nader, K. A. Grant, H. M. L. Davies, R. H. Mach, and S. R. Childers The Reinforcing and Discriminative Stimulus Effects of the Novel Cocaine Analog 2beta -Propanoyl-3beta -(4-Tolyl)-Tropane in Rhesus Monkeys J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 541 - 550. [Abstract] [Full Text]